class="knockout" style="margin-top: 0px;margin-bottom: 1px;font-size: 14px;line-height: 1.2;padding: 5px;padding-left: 20px;padding-right: 20px;font-weight: normal;">THANK YOU FOR SUBSCRIBING
Todd J. Vento, Medical Director for the Infectious Diseases Telehealth Program, Intermountain Healthcare
Laurie Goodman, Board Manager & CEO,ClearLight Biotechnologies
Robert Balog, Founder & CEO,BioCeryx
Prof. Dr. Heinz-Herbert Fiebig, CEO and Dr. Vincent Vuaroqueaux, CTO,4HF Biotec
Akseli Hemminki, Founder & CEO,TILT Biotherapeutics
Maximilian Ottosson, Co-Founder & CEO,Cellevate
Owe Orwar, CEO,Oblique Therapeutics
Kanae Gamo, Vice President, Biology and Co-founder, Yusuke Tominari, Ph.D. CEO, CSO, and Co-founder,FIMECS
Yoshiyuki Sakuraba, Ph.D., CEO and Yoko Nagai, Ph.D., CTO,Varinos
Ulrich Geilinger, Venture Capitalist, HBM Partners AG
Amanda Hayward, Managing Director, Venture Capital Investments, Connecticut Innovations
Richard Hu, Associate Director CMC, Curis
Seungpyo Hong, Co-Founder & President,Capio Biosciences